Minocycline in Multiple Sclerosis — Compelling Results but Too Early to Tell

Care for persons with multiple sclerosis has evolved as options for disease-modifying treatments have expanded. The high cost of current treatments has stimulated interest in repurposing existing, lower-cost drugs as new therapies for multiple sclerosis. One appealing candidate is minocycline, a…

http://ift.tt/2sgHxCR